Lupin reported INR78.27B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Bharat Petroleum INR 1.49T 19.2B Sep/2026
Cipla INR 74.04B 2.85B Sep/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Dr.Reddys Laboratories INR 86.98B 6.27B Sep/2026
Sun Pharmaceuticals INR 161.99B 8.99B Sep/2026
UPL INR 118.6B 16.79B Sep/2026